PortfoliosLab logo
CLOV vs. ALHC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CLOV and ALHC is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

CLOV vs. ALHC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and Alignment Healthcare Holdings, LLC (ALHC). The values are adjusted to include any dividend payments, if applicable.

-60.00%-40.00%-20.00%0.00%20.00%December2025FebruaryMarchAprilMay
-49.95%
-10.92%
CLOV
ALHC

Key characteristics

Sharpe Ratio

CLOV:

4.08

ALHC:

2.08

Sortino Ratio

CLOV:

4.64

ALHC:

2.77

Omega Ratio

CLOV:

1.57

ALHC:

1.35

Calmar Ratio

CLOV:

4.36

ALHC:

1.70

Martin Ratio

CLOV:

24.60

ALHC:

12.41

Ulcer Index

CLOV:

17.10%

ALHC:

10.27%

Daily Std Dev

CLOV:

83.78%

ALHC:

61.84%

Max Drawdown

CLOV:

-97.16%

ALHC:

-83.61%

Current Drawdown

CLOV:

-82.85%

ALHC:

-43.45%

Fundamentals

Market Cap

CLOV:

$1.69B

ALHC:

$3.07B

EPS

CLOV:

-$0.09

ALHC:

-$0.47

PS Ratio

CLOV:

1.23

ALHC:

1.02

PB Ratio

CLOV:

4.95

ALHC:

28.32

Total Revenue (TTM)

CLOV:

$1.02B

ALHC:

$3.00B

Gross Profit (TTM)

CLOV:

$283.04M

ALHC:

$347.34M

EBITDA (TTM)

CLOV:

-$22.08M

ALHC:

-$40.24M

Returns By Period

In the year-to-date period, CLOV achieves a 19.05% return, which is significantly lower than ALHC's 37.07% return.


CLOV

YTD

19.05%

1M

8.07%

6M

2.18%

1Y

330.74%

5Y*

N/A

10Y*

N/A

ALHC

YTD

37.07%

1M

-18.63%

6M

11.90%

1Y

127.43%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CLOV vs. ALHC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV
The Risk-Adjusted Performance Rank of CLOV is 9999
Overall Rank
The Sharpe Ratio Rank of CLOV is 100100
Sharpe Ratio Rank
The Sortino Ratio Rank of CLOV is 9999
Sortino Ratio Rank
The Omega Ratio Rank of CLOV is 9797
Omega Ratio Rank
The Calmar Ratio Rank of CLOV is 9898
Calmar Ratio Rank
The Martin Ratio Rank of CLOV is 9999
Martin Ratio Rank

ALHC
The Risk-Adjusted Performance Rank of ALHC is 9494
Overall Rank
The Sharpe Ratio Rank of ALHC is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of ALHC is 9393
Sortino Ratio Rank
The Omega Ratio Rank of ALHC is 9191
Omega Ratio Rank
The Calmar Ratio Rank of ALHC is 9292
Calmar Ratio Rank
The Martin Ratio Rank of ALHC is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CLOV vs. ALHC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Alignment Healthcare Holdings, LLC (ALHC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current CLOV Sharpe Ratio is 4.08, which is higher than the ALHC Sharpe Ratio of 2.08. The chart below compares the historical Sharpe Ratios of CLOV and ALHC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00December2025FebruaryMarchAprilMay
4.08
2.08
CLOV
ALHC

Dividends

CLOV vs. ALHC - Dividend Comparison

Neither CLOV nor ALHC has paid dividends to shareholders.


TTM2024202320222021
CLOV
Clover Health Investments, Corp.
0.00%0.00%0.00%0.00%2.69%
ALHC
Alignment Healthcare Holdings, LLC
0.00%0.00%0.00%0.00%0.00%

Drawdowns

CLOV vs. ALHC - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.16%, which is greater than ALHC's maximum drawdown of -83.61%. Use the drawdown chart below to compare losses from any high point for CLOV and ALHC. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%December2025FebruaryMarchAprilMay
-82.85%
-43.45%
CLOV
ALHC

Volatility

CLOV vs. ALHC - Volatility Comparison

Clover Health Investments, Corp. (CLOV) has a higher volatility of 16.32% compared to Alignment Healthcare Holdings, LLC (ALHC) at 15.33%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than ALHC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


8.00%10.00%12.00%14.00%16.00%18.00%20.00%22.00%December2025FebruaryMarchAprilMay
16.32%
15.33%
CLOV
ALHC

Financials

CLOV vs. ALHC - Financials Comparison

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Alignment Healthcare Holdings, LLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-500.00M0.00500.00M1.00B20212022202320242025
336.96M
926.93M
(CLOV) Total Revenue
(ALHC) Total Revenue
Values in USD except per share items

CLOV vs. ALHC - Profitability Comparison

The chart below illustrates the profitability comparison between Clover Health Investments, Corp. and Alignment Healthcare Holdings, LLC over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-10.0%0.0%10.0%20.0%30.0%20212022202320242025
27.9%
11.4%
(CLOV) Gross Margin
(ALHC) Gross Margin
CLOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a gross profit of 93.92M and revenue of 336.96M. Therefore, the gross margin over that period was 27.9%.

ALHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Alignment Healthcare Holdings, LLC reported a gross profit of 106.03M and revenue of 926.93M. Therefore, the gross margin over that period was 11.4%.

CLOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported an operating income of -21.45M and revenue of 336.96M, resulting in an operating margin of -6.4%.

ALHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Alignment Healthcare Holdings, LLC reported an operating income of -5.39M and revenue of 926.93M, resulting in an operating margin of -0.6%.

CLOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a net income of -22.09M and revenue of 336.96M, resulting in a net margin of -6.6%.

ALHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Alignment Healthcare Holdings, LLC reported a net income of -9.11M and revenue of 926.93M, resulting in a net margin of -1.0%.